VERU
NASDAQ
$2.30
Veru Inc (VERU)
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $24.50 (+965.22%)
Market Cap
$39M
FCF 5Y CAGR
+66.51%
Free Cash Flow Yield
-67.09%
Beta (5Y)
1.50
Price Chart
Valuation
Market Cap$39M
Forward P/E117.65
PEG3.60
P/S3.11
P/B1.18
Profitability
Gross Profit (TTM)$5.85M
EBITDA-$19M
EPS-$0.90
Financial Health
Free Cash Flow Yield-67.09%
Growth & Risk
EPS 5Y CAGR-19.99%
FCF 5Y CAGR+66.51%
Beta (5Y)1.50
Sharpe Ratio-0.45